Cargando…

Comparison between the HLA-B(∗)58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions

Severe cutaneous adverse drug reactions (SCARs) are life-threatening reactions. The strong association between the HLA-B(∗)58 : 01 allele and allopurinol-induced SCARs is well recognized. Screening for HLA-B(∗)58 : 01 allele before prescribing allopurinol in some populations has been recommended. Se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saksit, Niwat, Nakkam, Nontaya, Konyoung, Parinya, Khunarkornsiri, Usanee, Tassaneeyakul, Wongwiwat, Chumworathayi, Pansu, Kanjanawart, Sirimas, Sukasem, Chonlaphat, Sangviroon, Alisara, Pattanacheewapull, Oranuch, Tassaneeyakul, Wichittra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748122/ https://www.ncbi.nlm.nih.gov/pubmed/29392141 http://dx.doi.org/10.1155/2017/2738784

Ejemplares similares

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
por: Nakkam, Nontaya, et al.
Publicado: (2018)

Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions
por: Wattanachai, Pansakon, et al.
Publicado: (2023)

HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients
por: Satapornpong, Patompong, et al.
Publicado: (2021)

Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
por: Khaeso, Kanyarat, et al.
Publicado: (2021)

Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01
por: Pratoomwun, Jirawat, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
por: Saokaew, Surasak, et al.
Publicado: (2014)

HLA-B(*)58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
por: Sukasem, Chonlaphat, et al.
Publicado: (2016)

HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
por: Jantararoungtong, Thawinee, et al.
Publicado: (2014)

New Advances in Drug Hypersensitivity Research and Treatment
por: Tsai, Yi-Giien, et al.
Publicado: (2018)

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
por: Koomdee, Napatrupron, et al.
Publicado: (2017)

The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients
por: Wattanachai, Nitsupa, et al.
Publicado: (2017)

Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication
por: Chunlertlith, Kitti, et al.
Publicado: (2017)

SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome
por: Makarawate, Pattarapong, et al.
Publicado: (2017)

Allopurinol non-covalently facilitates binding of unconventional peptides to HLA-B*58:01
por: Huan, Xuelu, et al.
Publicado: (2023)

Management for improving patients’ knowledge and understanding about drug allergy
por: Jarernsiripornkul, Narumol, et al.
Publicado: (2015)

248 HLA-B58 Does not Increase Allopurinol Hypersensitivity among Patients with Hematologic Malignancy
por: Jung, Jae-Woo, et al.
Publicado: (2012)

Allopurinol-Induced Stevens–Johnson Syndrome in Javanese Men With Positive HLA‐B*58:01
por: Ferdiana, Astri, et al.
Publicado: (2022)

Evaluation of a pharmacogenetic test in Thailand for abacavir hypersensitivity screening in human immunodeficiency virus infection
por: Chonlaphat, Sukasem, et al.
Publicado: (2014)

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies
por: Wu, Ran, et al.
Publicado: (2016)

Allopurinol induced erythroderma
por: Sharma, Geeta, et al.
Publicado: (2013)

Allopurinol: Sorrow to the marrow
por: Raaju, UR, et al.
Publicado: (2020)

Allopurinol hypersensitivity syndrome
por: Yaseen, Wid, et al.
Publicado: (2023)

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
por: Ko, Tai-Ming, et al.
Publicado: (2015)

The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand
por: Bushyakanist, Asalaysa, et al.
Publicado: (2015)

Comparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug Reactions
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2016)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
por: Sessa, Francesco, et al.
Publicado: (2023)

Allopurinol-induced DRESS syndrome
por: Yaylacı, Selcuk, et al.
Publicado: (2012)

Transient hypofibrinogenemia due to allopurinol
por: Yin, ZhiQiang, et al.
Publicado: (2014)

Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B(*)58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions
por: Nguyen, Dinh Van, et al.
Publicado: (2017)

Allopurinol-induced severe cutaneous adverse reactions: A report of three cases with the HLA-B(*)58:01 allele who underwent lymphocyte activation test
por: Kim, Eun-Young, et al.
Publicado: (2017)

Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand
por: Sungkanuparph, Somnuek, et al.
Publicado: (2012)

A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study
por: Damronglerd, Pansachee, et al.
Publicado: (2015)

HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2017)

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
por: Tempark, Therdpong, et al.
Publicado: (2022)

Allopurinol-Induced Toxic Epidermal Necrolysis
por: Buenrostro-Rubio, Ignacio, et al.
Publicado: (2019)

Gold salts, D-penicillamine and allopurinol
por: Ueda, Shiro, et al.
Publicado: (2008)

Severe adverse drug reaction to allopurinol
por: Lucas, Grace, et al.
Publicado: (2022)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
por: Biswas, Mohitosh, et al.
Publicado: (2022)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6pgavfctn3kvhu5n7irpv0rlb6